1. DeMaria AN. Lies, damned lies, and statistics. J Am Coll Cardiol. 2008; 52:1430–1431. PMID:
18940535.
Article
2. Damaske A, Muxel S, Fasola F, Radmacher MC, Schaefer S, Jabs A, Orphal D, Wild P, Parker JD, Fineschi M, Munzel T, Forconi S, Gori T. Peripheral hemorheological and vascular correlates of coronary blood flow. Clin Hemorheol Microcirc. 2011; 49:261–269. PMID:
22214697.
Article
3. Lee BK, Durairaj A, Mehra A, Wenby RB, Meiselman HJ, Alexy T. Hemorheological abnormalities in stable angina and acute coronary syndromes. Clin Hemorheol Microcirc. 2008; 39:43–51. PMID:
18503109.
Article
4. Hacioglu G, Yalcin O, Bor-Kucukatay M, Ozkaya G, Baskurt OK. Red blood cell rheological properties in various rat hypertension models. Clin Hemorheol Microcirc. 2002; 26:27–32. PMID:
11904468.
5. Carter C, McGee D, Reed D, Yano K, Stemmermann G. Hematocrit and the risk of coronary heart disease: the Honolulu Heart Program. Am Heart J. 1983; 105:674–679. PMID:
6837420.
Article
6. Corti R, Fuster V, Badimon JJ. Pathogenetic concepts of acute coronary syndromes. J Am Coll Cardiol. 2003; 41(4 Suppl S):7S–14S. PMID:
12644335.
Article
7. Marossy A, Svorc P, Kron I, Gresova S. Hemorheology and circulation. Clin Hemorheol Microcirc. 2009; 42:239–258. PMID:
19628890.
Article
8. Shin S, Ku YH, Ho JX, Kim YK, Suh JS, Singh M. Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes mellitus. Clin Hemorheol Microcirc. 2007; 36:253–261. PMID:
17361027.
9. American Diabetes Association. Standards of medical care in diabetes: 2014. Diabetes Care. 2014; 37(Suppl 1):S14–S80. PMID:
24357209.
10. Singh M, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny WF, Holmes DR Jr. Predictive factors for ischemic target vessel revascularization in the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial. J Am Coll Cardiol. 2005; 45:198–203. PMID:
15653015.
Article
11. Shin S, Ku Y. Hemorheology and clinical application: association of impairment of red blood cell deformability with diabetic nephropathy. Korea Aust Rheol J. 2005; 17:117–123.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28:412–419. PMID:
3899825.
13. Napoli C, Ignarro LJ. Nitric oxide-releasing drugs. Annu Rev Pharmacol Toxicol. 2003; 43:97–123. PMID:
12540742.
Article
14. Bor-Kucukatay M, Wenby RB, Meiselman HJ, Baskurt OK. Effects of nitric oxide on red blood cell deformability. Am J Physiol Heart Circ Physiol. 2003; 284:H1577–H1584. PMID:
12521942.
Article
15. Singh M, Shin S. Changes in erythrocyte aggregation and deformability in diabetes mellitus: a brief review. Indian J Exp Biol. 2009; 47:7–15. PMID:
19317346.
16. Marcinkowska-Gapinska A, Kowal P. Blood fluidity and thermography in patients with diabetes mellitus and coronary artery disease in comparison to healthy subjects. Clin Hemorheol Microcirc. 2006; 35:473–479. PMID:
17148846.
17. Singleton JR, Smith AG, Russell JW, Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes. 2003; 52:2867–2873. PMID:
14633845.
Article
18. Ando J, Yamamoto K. Vascular mechanobiology: endothelial cell responses to fluid shear stress. Circ J. 2009; 73:1983–1992. PMID:
19801852.
19. Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther. 2008; 88:1322–1335. PMID:
18801863.
Article
20. Kesmarky G, Toth K, Habon L, Vajda G, Juricskay I. Hemorheological parameters in coronary artery disease. Clin Hemorheol Microcirc. 1998; 18:245–251. PMID:
9741664.
21. Cecchi E, Marcucci R, Paniccia R, Bandinelli B, Valente S, Giglioli C, Lazzeri C, Gensini GF, Abbate R, Mannini L. Effect of blood hematocrit and erythrocyte deformability on adenosine 5’-diphosphate platelet reactivity in patients with acute coronary syndromes on dual antiplatelet therapy. Am J Cardiol. 2009; 104:764–768. PMID:
19733708.
Article
22. Resmi H, Akhunlar H, Temiz Artmann A, Guner G. In vitro effects of high glucose concentrations on membrane protein oxidation, G-actin and deformability of human erythrocytes. Cell Biochem Funct. 2005; 23:163–168. PMID:
15386536.
Article
23. Brown CD, Ghali HS, Zhao Z, Thomas LL, Friedman EA. Association of reduced red blood cell deformability and diabetic nephropathy. Kidney Int. 2005; 67:295–300. PMID:
15610255.
Article
24. Xue S, Lee BK, Shin S. Disaggregating shear stress: the roles of cell deformability and fibrinogen concentration. Clin Hemorheol Microcirc. 2013; 55:231–240. PMID:
23089881.
Article
25. Shin S, Nam JH, Hou JX, Suh JS. A transient, microfluidic approach to the investigation of erythrocyte aggregation: the threshold shear-stress for erythrocyte disaggregation. Clin Hemorheol Microcirc. 2009; 42:117–125. PMID:
19433885.
Article
26. Satoh K. Dipeptidyl peptidase-4 inhibitors: emerging player for vascular protection. Circ J. 2013; 77:1156–1157. PMID:
23386273.
27. Aroor AR, Sowers JR, Jia G, DeMarco VG. Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system. Am J Physiol Heart Circ Physiol. 2014; 307:H477–H492. PMID:
24929856.
Article